Table 2. Correlations of the expression of CXCLs and biomarkers of TIICs in HCC (GEPIA).
Types of TIICs | Gene markers | CXCL9 | CXCL10 | CXCL2 | CXCL12 | CXCL14 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
r | P | r | P | r | P | r | P | R | P | ||
B cell | CD19 | 0.4 | 1.6E−15 | 0.3 | 7.3E−09 | 0.033 | 0.53 | 0.32 | 2.2E−10 | 0.41 | 1.2E−16 |
CD79A | 0.61 | 1.1E−38 | 0.42 | 5.0E−17 | 0.11 | 0.03 | 0.5 | 3E−24 | 0.52 | 6.4E−27 | |
T cell (general) | CD3D | 0.56 | 1.8E−32 | 0.44 | 1.7E−18 | 0.098 | 0.059 | 0.25 | 8.7E−07 | 0.4 | 2.6E−15 |
CD2 | 0.67 | 5.4E−49 | 0.53 | 1.9E−28 | 0.19 | 0.00035 | 0.44 | 3E−19 | 0.47 | 8E−22 | |
Th1 | TBX21 | 0.72 | 8.2E−61 | 0.6 | 8.3E−38 | 0.18 | 0.00073 | 0.42 | 5.4E−17 | 0.35 | 6.3E−12 |
STAT4 | 0.37 | 1.4E−13 | 0.4 | 2.7E−15 | 0.27 | 2.3E−07 | 0.32 | 2.5E−10 | 0.32 | 3.5E−10 | |
STAT1 | 0.57 | 5.9E−33 | 0.56 | 1E−31 | 0.059 | 0.26 | 0.32 | 6E−10 | 0.25 | 1.3E−06 | |
TNF | 0.51 | 7.4E−26 | 0.37 | 1.9E−13 | 0.15 | 0.0046 | 0.38 | 8.5E−14 | 0.38 | 2.3E−14 | |
IFNG | 0.69 | 4.9E−53 | 0.55 | 2.5E−30 | 0.016 | 0.76 | 0.15 | 0.0029 | 0.26 | 4.7E−07 | |
Th2 | GATA3 | 0.53 | 5.9E−28 | 0.37 | 1.4E−13 | 0.19 | 0.00017 | 0.49 | 1.7E−23 | 0.53 | 3.3E−28 |
STAT6 | 0.15 | 0.0029 | 0.14 | 0.0065 | 0.11 | 0.03 | 0.12 | 0.024 | 0.098 | 0.059 | |
IL13 | 0.19 | 0.00019 | 0.16 | 0.0022 | 0.025 | 0.63 | 0.029 | 0.58 | 0.13 | 0.013 | |
STAT5A | 0.39 | 4.5E−15 | 0.36 | 1.8E−12 | 0.088 | 0.091 | 0.3 | 4.2E−09 | 0.29 | 1.1E−08 | |
Tfh | BCL6 | 0.23 | 6.4E−06 | 0.18 | 0.00038 | 0.076 | 0.14 | 0.084 | 0.11 | 0.045 | 0.39 |
IL21 | 0.36 | 1.4E−12 | 0.29 | 9.4E−09 | −0.066 | 0.2 | 0.11 | 0.03 | 0.14 | 0.0087 | |
Th17 | STAT3 | 0.22 | 1.3E−05 | 0.18 | 0.00059 | 0.33 | 8.9E−11 | 0.26 | 3.1E−07 | 0.23 | 9.8E−06 |
IL17A | 0.066 | 0.21 | 0.11 | 0.035 | 0.076 | 0.15 | 0.033 | 0.52 | 0.035 | 0.51 | |
Treg | FOXP3 | 0.48 | 3.3E−22 | 0.46 | 6.4E−21 | 0.13 | 0.014 | 0.15 | 0.0049 | 0.19 | 0.00017 |
CCR8 | 0.55 | 2.2E−30 | 0.47 | 1.1E−21 | 0.18 | 0.00036 | 0.32 | 3.6E−10 | 0.31 | 2.1E−09 | |
TGFB1 | 0.32 | 2.3E−10 | 0.13 | 0.015 | 0.075 | 0.15 | 0.48 | 3.9E−23 | 0.51 | 3.6E−26 | |
CD8+ T | CD8A | 0.71 | 1.5E−58 | 0.54 | 1.2E−29 | 0.16 | 0.0024 | 0.44 | 1.6E−18 | 0.42 | 1.9E−17 |
CD8B | 0.65 | 1.5E−46 | 0.49 | 1.4E−23 | 0.11 | 0.043 | 0.35 | 2.4E−12 | 0.39 | 1E−14 | |
Exhausted T cell | PDCD1 | 0.62 | 5.2E−40 | 0.42 | 1.4E−17 | 0.058 | 0.27 | 0.37 | 3.9E−13 | 0.4 | 1.3E−15 |
CTLA4 | 0.66 | 8.3E−48 | 0.47 | 6.6E−22 | 0.15 | 0.0035 | 0.24 | 3.4E−06 | 0.35 | 2.3E−12 | |
LAG3 | 0.48 | 3.8E−23 | 0.38 | 6.8E−14 | −0.017 | 0.75 | 0.15 | 0.0035 | 0.24 | 3.3E−06 | |
TIM3 | 0.54 | 5.5E−29 | 0.4 | 9.5E−16 | 0.18 | 0.00052 | 0.42 | 2.6E−17 | 0.47 | 2.7E−21 | |
GZMB | 0.58 | 1.1E−34 | 0.42 | 2.2E−17 | 0.094 | 0.072 | 0.23 | 9.5E−06 | 0.28 | 3.5E−08 | |
NK cell | KIR2DL1 | 0.26 | 2.8E−07 | 0.19 | 0.00033 | 0.15 | 0.0036 | 0.12 | 0.023 | 0.12 | 0.022 |
KIR2DL3 | 0.4 | 1.6E−15 | 0.31 | 8.7E−10 | 0.045 | 0.82 | 0.16 | 0.002 | 0.19 | 0.00033 | |
KIR3DL1 | 0.27 | 1.9E−07 | 0.25 | 1.3E−06 | 0.13 | 0.015 | 0.13 | 0.01 | 0.052 | 0.32 | |
KIR3DL2 | 0.43 | 2.3E−18 | 0.3 | 4E−09 | 0.024 | 0.65 | 0.29 | 2.1E−08 | 0.27 | 1E−07 | |
KIR3DL3 | 0.16 | 0.0019 | 0.13 | 0.012 | −0.012 | 0.82 | −0.01 | 0.84 | 0.073 | 0.16 | |
KIR2DS4 | 0.26 | 3E−07 | 0.22 | 1.4E−05 | 0.062 | 0.24 | 0.16 | 0.0025 | 0.083 | 0.11 | |
Neutrophil | CD11b | 0.32 | 4.8E−10 | 0.35 | 4.9E−12 | 0.22 | 1.6E−05 | 0.24 | 1.9E−06 | 0.28 | 7.5E−08 |
CCR7 | 0.57 | 7.4E−33 | 0.42 | 1.4E−17 | 0.29 | 1.2E−08 | 0.55 | 3.7E−30 | 0.5 | 1.6E−24 | |
CD66b | 0.081 | 0.12 | 0.036 | 0.49 | 0.046 | 0.38 | 0.033 | 0.53 | 0.055 | 0.29 | |
M1 TAM | NOS2 | 0.13 | 0.016 | 0.13 | 0.015 | 0.11 | 0.039 | 0.25 | 1.2E−06 | 0.14 | 0.0053 |
PTGS2 | 0.3 | 2.6E−09 | 0.19 | 0.00018 | 0.34 | 2.2E−11 | 0.6 | 5.8E−37 | 0.53 | 3.7E−28 | |
IRF5 | 0.18 | 0.00061 | 0.19 | 0.00024 | 0.035 | 0.5 | 0.078 | 0.13 | 0.12 | 0.017 | |
M2 TAM | CD163 | 0.43 | 1.2E−17 | 0.39 | 3.8E−15 | 0.24 | 2.2E−06 | 0.42 | 5.3E−17 | 0.4 | 7.3E−16 |
VSIG4 | 0.38 | 5.9E−14 | 0.36 | 8.4E−13 | 0.28 | 5.2E−08 | 0.42 | 2.3E−17 | 0.4 | 2.6E−15 | |
MS4A4A | 0.48 | 6.8E−23 | 0.42 | 3.4E−17 | 0.28 | 7.8E−08 | 0.45 | 1.4E−19 | 0.34 | 2.6E−11 | |
TAM | CCL2 | 0.37 | 4.2E−13 | 0.3 | 6.9E−09 | 0.27 | 1.7E−07 | 0.58 | 6.8E−35 | 0.54 | 2.3E−29 |
CD68 | 0.37 | 3.0E−13 | 0.28 | 4.5E−08 | 0.11 | 0.037 | 0.37 | 1.4E−13 | 0.26 | 2.5E−07 | |
IL10 | 0.46 | 3.5E−21 | 0.35 | 4.4E−12 | 0.13 | 0.016 | 0.37 | 1E−13 | 0.29 | 1.9E−08 | |
Monocyte | CD86 | 0.58 | 9.5E−35 | 0.46 | 1.2E−20 | 0.18 | 0.00038 | 0.48 | 3.5E−22 | 0.45 | 5E−20 |
CD115 | 0.49 | 3.7E−24 | 0.4 | 1.1E−15 | 0.23 | 5.6E−06 | 0.53 | 8.7E−28 | 0.46 | 1.3E−20 | |
DC | HLA-DPB1 | 0.57 | 1.6E−33 | 0.47 | 3E−21 | 0.23 | 7.1E−06 | 0.53 | 1.3E−27 | 0.47 | 9.3E−22 |
HLA-DRA | 0.6 | 7.1E−38 | 0.5 | 6.1E−25 | 0.28 | 7.5E−08 | 0.49 | 8.7E−24 | 0.43 | 2.8E−18 | |
HLA-DQB1 | 0.43 | 6.8E−18 | 0.3 | 5E−09 | 0.13 | 0.013 | 0.28 | 3.3E−08 | 0.32 | 4.6E−10 | |
HLA-DPA1 | 0.6 | 3.1E−37 | 0.5 | 3.3E−24 | 0.27 | 9.4E−08 | 0.5 | 6.7E−25 | 0.43 | 6.9E−18 | |
CD1C | 0.38 | 2.1E−14 | 0.31 | 1.1E−09 | 0.2 | 8.8E−05 | 0.57 | 1.8E−33 | 0.45 | 1.3E−19 | |
NRP1 | 0.24 | 2E−06 | 0.14 | 0.0058 | 0.071 | 0.18 | 0.33 | 4.9E−11 | 0.28 | 3.3E−08 | |
CD11c | 0.51 | 1.3E−25 | 0.41 | 1.1E−16 | 0.22 | 1.3E−05 | 0.4 | 2.4E−15 | 0.41 | 3.8E−16 |
Note: The correlation analysis was adjusted for the tumor purity. P values with statistical significance are shown in bold. TAM, tumor-associated macrophage; Tfh, follicular helper T cell; Th, helper T cell; Treg, regulatory T cell; NK cell, natural killer cell; r, the correlation coefficient of Spearman’s analysis.